Charles Schwab Investment Management Inc Castle Biosciences Inc Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 235,015 shares of CSTL stock, worth $5.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235,015
Previous 242,258
2.99%
Holding current value
$5.41 Million
Previous $4.85 Million
1.05%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CSTL
# of Institutions
169Shares Held
27.3MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$70.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$49.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$41.4 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$34.3 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$31.7 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $605M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...